Skip to content
GC
Company

Updated:

Gamida Cell Ltd.

Gamida Cell Ltd. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001600847, and its reported industry is...

Overview

Gamida Cell Ltd. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001600847, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2024-03-27, it reported annual revenue of USD 1,784,000; net income of USD -62,996,000; total assets of USD 102,186,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Gamida Cell Ltd.
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
Jerusalem, Israel
Incorporated in
L3
Fiscal year end
December 31
SEC CIK
0001600847

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2023USD$1.8M-$63.0M$102.2M$46.6M-$79.1M
FY2022USD—-$79.4M$124.8M$64.7M-$70.4M
FY2021USD—-$89.8M$148.8M$55.9M-$81.8M
FY2020USD—-$72.7M$155.5M$127.2M-$48.6M

Recent SEC filings

FormFiledPeriodFiling
8-KCURRENT REPORT
10-QQUARTERLY REPORT
8-KCURRENT REPORT
10-KANNUAL REPORT
8-KCURRENT REPORT
8-KCURRENT REPORT
SC 13G—Form SC 13G
8-KCURRENT REPORT
8-KCURRENT REPORT
8-KCURRENT REPORT
8-KCURRENT REPORT
8-KCURRENT REPORT

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Gamida Cell Ltd. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Gamida Cell Ltd. | Jerusalem Company | Altss